Search

The complex [PtMe(Obpy)(OAc)2(H2O)], 2a, Obpy = 2,2'-bipyridine N-oxide, is prepared through the reaction of [PtMe(Obpy)(SMe2)], 1a, by 1 equiv of PhI(OAc)2 via an oxidative addition (OA) reaction. Pt(IV) complex 2a attends the process of C-O bond reductive elimination (RE) reaction to form methyl acetate and corresponding Pt(II) complex [Pt(Obpy)(OAc)(H2O)], 3a. The kinetic of OA and RE reactions are investigated by means of different spectroscopies. The obtained results show that the reaction rates of OA step of 1a are faster than its analogous complex [PtMe(ppy)(SMe2)], 1b, ppy = 2-phenylpyridine. The density functional theory (DFT) calculations signify that the OA reaction initiated by a nucleophilic attack of the platinum(II) central atom of 1b on the iodine(III) atom while it had commenced by a nucleophilic substitution reaction of coordinated SMe2 in 1a with a carbonyl oxygen atom of PhI(OAc)2. Our calculation revealed that the key step for 1a is an acetate transfer from the I(III) to Pt(II) through a formation of square pyramidal iodonium complex. This can be attributed to the more electron-withdrawing character of Obpy ligand than to ppy which reduces the nucleophilicity of Pt atom in 1a. Furthermore, 2a with electron-withdrawing Obpy ligand prone to C-O bond formation faster than complex [PtMe(ppy)(OAc)2(H2O)], 2b, with an electron-rich ppy ligand which conforms to the anticipation that REs occur faster on electron-poor metal centers.

Practical Pd-catalyzed 2-pyridones were designed to achieve chromeno[2,3-b]pyridine-2-ones. The reaction proceeds through domino nucleophilic addition and decarboxylative arylation, respectively. This methodology offers a moderately efficient approach to construct the bioactive, fused-heterocyclic skeletons via selective C-O bond formation and decarboxylative arylation in a single step with high selectivity and good yields.

Three new alkaline earth metal–organic frameworks (MOFs), [Mg2(BDC-OH)2(DMF)3] (Mg-HBDC), [Ca(BDC-OH)(DMF)2] (Ca-HBDC), and [Sr(BDC-OH)(DMF)] (Sr-HBDC) (BDC-OH = 2-hydroxyterephthalate(2−) anion and DMF = N,N-dimethylformamide), were synthesized by the assembly of BDC-OH and nitrate salts of the metal ions under solvothermal conditions. Single-crystal structure analysis revealed that Ca-HBDC and Sr-HBDC are isostructural to their corresponding MOFs containing 2,5-dihydroxyterephthalalate(2−) anion (H2dhtp) and terephthalate(2−) anion (BDC), respectively. The MOFs were also characterized by Fourier transform infrared spectroscopy, thermogravimetric analysis, and powder X-ray diffraction. The obtained MOFs were applied as heterogeneous basic catalysts for the Knoevenagel condensation reaction at room temperature. The catalysts showed good catalytic activity and structural stability in the condensation reaction and could be reused without observable loss of activity.

Designable coordination polymers with suitable chemical diversities and biocompatible structures have been proposed as a promising class of vehicles for drug delivery systems. Here, we hydrothermally synthesized a novel one-dimensional (1D) coordination polymer, [Zn(H2O)6K2(H2BTC)2(H2O)4](H2BTC)2·2H2O, where H3BTC = benzene-1,3,5-tricarboxylic acid (trimesic acid), cp.1. As the hydrogen bonds stabilized 1D chains in three dimensions, the cp.1 could be a good candidate for delivering small-molecule chemotherapeutics such as 5-fluorouracil (5-Fu). The synthesized cp.1 showed a remarkable 5-Fu loading of 66% with encapsulation efficiency of 98% and almost complete release process. The 5-Fu-loaded cp.1 displayed a time-dependent cytotoxicity effect against breast cancer cell lines MCF-7 and 4T1. The cellular uptake of cp.1 particles was investigated via confocal laser scanning microscopy using fluorescein isothiocyanate and LysoTracker Red staining. Furthermore, the in vivo antitumor impact of 5-Fu-loaded cp.1 was studied on 4T1 breast cancer BALB/c mice model. The intratumor treatment of 5-Fu-loaded cp.1 demonstrated beneficial antitumor efficacy by postponing tumor growth. These results suggest that the 5-Fu-loaded cp.1 microparticles with a great locoregional delivery can be efficient anticancer drug carriers for further clinical treatments.